✦ LIBER ✦

Nilotinib effective in imatinib-resistant/intolerant CML

✍ Scribed by McRae, K

Book ID: 120847823
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2007
Weight: 197 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200715750-00018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN13 Cost-Effectiveness Analysis of Nil

PCN13 Cost-Effectiveness Analysis of Nilotinib Versus Dasatinib in Patients With Imatinib-Resistant or Imatinib-Intolerant Chronic Myeloid Leukemia (CML)

✍ Niu, X.; Hay, J. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Dasatinib, nilotinib effective for imati

Dasatinib, nilotinib effective for imatinib-resistant CML and ALL

📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl ⚖ 121 KB

Nilotinib in Imatinib-Resistant CML and

Nilotinib in Imatinib-Resistant CML and Philadelphia Chromosome–Positive ALL

✍ Kantarjian, Hagop; Giles, Francis; Wunderle, Lydia; Bhalla, Kapil; O'Brien, Susa 📂 Article 📅 2006 🏛 Massachusetts Medical Society 🌐 English ⚖ 186 KB

NICE guidance on dasatinib, high-dose im

NICE guidance on dasatinib, high-dose imatinib, and nilotinib for patients with CML who are resistant or intolerant to imatinib

✍ Scott Goulden; Frances Sutcliffe; Andrew Stevens 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 47 KB

Dasatinib is effective in imatinib-resis

Dasatinib is effective in imatinib-resistant CML

✍ Emma Cannell 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 40 KB

Bosutinib induces high response rates in

Bosutinib induces high response rates in imatinib-resistant/intolerant CML patients

✍ NEIL OSTERWEIL 📂 Article 📅 2010 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 59 KB